NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Positives from ASM:
1) already in discussions for regional partnering: geographical partnering (think by country or region).Spent a lot of money (on patents) so they would have ability to do deals with countries/regions. Already in exporatory discussions of the possibilities of a regional deal.
2) Already dealing with expansion of management: consultants will move seamlessly into staff
3) Direct: already selected Ph 2 cancers and hospitals.
4) BP partnering begins with combo trials. She mentioned checkpoint inhibitors.
5) Dr. Kalinki has moved back to Pittsburgh from Roswell and that has caused academic trials have been temporarily stopped while his move gets sorted out. Those trials soon begin again.
6) Ovarian trial will be first clinical trial, a combo trial. A conditioning regiment, a DC, and another component. NWBO did a small pilot control with Penn, which was "striking." Penn continued to work with DCs beyond NWBO trial and has published data from their continued work in ovarian cancer. (Think DCVax).
7) 2026: compassionate care for more solid cancers and to offer Direct, as well as L.
8) Dr. Kinlinski's work and compassionate in the US Pittsburgh lab. Sawston will do commercial production (when and if approved).
9) Put to rest FUDsters claims that we'll run through $9m just approved. That money is so that NWBO has negotiating power to deal with "pretty significant" events to get better terms.

I put this together pretty quickly. You should read script on NWBO wecsite.